SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-08-051904
Filing Date
2008-08-11
Accepted
2008-08-11 16:36:52
Documents
11
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a08-19213_110q.htm 10-Q 1315371
2 EX-10.1 a08-19213_1ex10d1.htm EX-10.1 29533
3 EX-10.2 a08-19213_1ex10d2.htm EX-10.2 29629
4 EX-10.3 a08-19213_1ex10d3.htm EX-10.3 29188
5 EX-31.1 a08-19213_1ex31d1.htm EX-31.1 12451
6 EX-31.2 a08-19213_1ex31d2.htm EX-31.2 10623
7 EX-32.1 a08-19213_1ex32d1.htm EX-32.1 8021
8 GRAPHIC g192131koi001.jpg GRAPHIC 3134
9 GRAPHIC g192131ba01i001.jpg GRAPHIC 10312
10 GRAPHIC g192131kmi001.jpg GRAPHIC 3134
11 GRAPHIC g192131kki001.jpg GRAPHIC 3134
  Complete submission text file 0001104659-08-051904.txt   1464092
Mailing Address 1400 SEAPORT BLVD. REDWOOD CITY CA 94063
Business Address 1400 SEAPORT BLVD. REDWOOD CITY CA 94063 650-454-1000
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19756 | Film No.: 081006813
SIC: 2836 Biological Products, (No Diagnostic Substances)